Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis.
Sheng LiYuqing WuDongxue YangChunyan WuChunmei MaXue LiuPaul N MoynaghBingwei WangGang HuShuo YangPublished in: The Journal of experimental medicine (2019)
The NLRP3 inflammasome is critical for EAE pathogenesis; however, the role of gasdermin D (GSDMD), a newly identified pyroptosis executioner downstream of NLRP3 inflammasome, in EAE has not been well defined. Here, we observed that the levels of GSDMD protein were greatly enhanced in the CNS of EAE mice, especially near the areas surrounding blood vessels. GSDMD was required for the pathogenesis of EAE, and GSDMD deficiency in peripheral myeloid cells impaired the infiltration of immune cells into the CNS, leading to the suppression of neuroinflammation and demyelination. Furthermore, the loss of GSDMD reduced the activation and differentiation of T cell in the secondary lymphoid organs and prevented T cell infiltration into CNS of EAE. The administration of inflammasome-related cytokines partially rescued the impairment of pathogenesis of EAE in GSDMD KO mice. Collectively, these findings provide the first demonstration of GSDMD in peripheral myeloid cells driving neuroinflammation during EAE pathogenesis.
Keyphrases
- nlrp inflammasome
- induced apoptosis
- cell cycle arrest
- dendritic cells
- traumatic brain injury
- lipopolysaccharide induced
- blood brain barrier
- endoplasmic reticulum stress
- cell death
- type diabetes
- signaling pathway
- immune response
- lps induced
- cell proliferation
- skeletal muscle
- small molecule
- insulin resistance
- replacement therapy